#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3992303	F	Reduction in amphetamine-induced hyperactivity in systemically dosed C57B/6 mouse model of schizophrenia administered at 30 mins after habituation in open field apparatus followed by amphetamine injection measured for 1 hr post dose	Mus musculus	1		organism-based format	Patent Bioactivity Data
2.	ALA3992305	B	Inhibition of asc-1 mediated [3H]-D-serine uptake in P2 fraction of rat forebrain synaptosomes after 4 mins by beta scintillation counting	Rattus norvegicus	14		subcellular format	Patent Bioactivity Data
3.	ALA3992306	B	Inhibition of ASCT2 mediated [3H]-D-serine uptake in rat hippocampal astrocytes	Rattus norvegicus	14		cell-based format	Patent Bioactivity Data
4.	ALA3992308	B	Potentiation of NMDA receptor mediated excitatory post-synaptic currents in the CA1 region of rat hippocampal slices upto 1 hr by whole-cell patch-clamp assay	Rattus norvegicus	14		assay format	Patent Bioactivity Data
5.	ALA3992312	B	Inhibition of human ASCT1 expressed in HEK cells assessed as reduction in [3H]-L-serine uptake after 1 min by beta counting analysis	Homo sapiens	12		cell-based format	Patent Bioactivity Data
6.	ALA3992313	B	Inhibition of human ASCT2 expressed in HEK cells assessed as reduction in [3H]-L-serine uptake after 1 min by beta counting analysis	Homo sapiens	12		cell-based format	Patent Bioactivity Data
7.	ALA3992314	B	Inhibition of ASCT2 mediated [3H]-L-serine uptake in rat hippocampal astrocytes after 5 mins by beta counting analysis	Rattus norvegicus	9		cell-based format	Patent Bioactivity Data
8.	ALA3992319	B	Inhibition of D-serine transporter in Sprague-Dawley rat visual cortex assessed as LTP threshold after 15 mins	Rattus norvegicus	9		assay format	Patent Bioactivity Data
9.	ALA3992321	B	Inhibition of ASCT2 mediated [3H]-D-serine uptake in rat hippocampal astrocytes at 1 mM after 5 mins by beta counting analysis	Rattus norvegicus	173		cell-based format	Patent Bioactivity Data
10.	ALA3992322	B	Inhibition of human ASCT1 expressed in HEK cells assessed as reduction in [3H]-D-serine uptake after 1 min by beta counting analysis	Homo sapiens	6		cell-based format	Patent Bioactivity Data
11.	ALA3992323	B	Inhibition of human ASCT2 expressed in HEK cells assessed as reduction in [3H]-D-serine uptake after 1 min by beta counting analysis	Homo sapiens	6		cell-based format	Patent Bioactivity Data
12.	ALA3992325	F	Reduction in amphetamine-induced hyperactivity in C57B/6 mouse model of schizophrenia at 0.3 mg/kg, ip administered at 30 mins after habituation in open field apparatus followed by amphetamine injection measured for 1 hr post dose	Mus musculus	1		organism-based format	Patent Bioactivity Data